Physician profile
Inga Bufano
NPI 1437185345
$5,590.33
in general payments reported to CMS, 2019-2025
34 companies · $586 in 2025
The $586 reported for 2025 was more than what 83% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,356 · 2022: $1,453 · 2023: $1,103 · 2024: $1,092 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,604 · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,604.02 |
| Education | $177.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $689.84 | 2021-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $626.24 | 2021-2024 | |
| Abbvie INC. | $607.72 | 2021-2024 | |
| Sun Pharmaceutical Industries INC. | $544.62 | 2021-2025 | Winlevi, Odomzo, Blu-U |
| Incyte Corporation | $355.45 | 2021-2025 | Opzelura |
| Allergan, INC. | $298.95 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $296.97 | 2021-2025 | |
| Leo Pharma INC. | $294.87 | 2021-2024 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $254.23 | 2022-2025 | Sotyktu |
| Lilly USA, LLC | $201.15 | 2022-2024 | Olumiant, Taltz, Zepbound |
| Janssen Biotech, INC. | $193.52 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $180.59 | 2021-2025 | |
| Galderma Laboratories, L.P. | $140.85 | 2021-2025 | Aklief, Nemluvio |
| Almirall LLC | $138.76 | 2021-2025 | Klisyri, Seysara |
| Pfizer INC. | $134.94 | 2021-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $115.09 | 2021-2023 | Otezla |
| Sanofi-Aventis U.S. LLC | $79.99 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $60.74 | 2021-2025 | Cabtreo |
| Dermavant Sciences, INC. | $51.14 | 2023-2024 | Vtama |
| Organon LLC | $36.96 | 2025 | Vtama |
| Botanix Sb INC | $35.50 | 2025 | Sofdra |
| Epi Health, LLC | $29.98 | 2022 | |
| Biofrontera INC. | $27.69 | 2021 | |
| Dermira, INC. | $26.34 | 2021 | |
| Strata Skin Sciences, INC. | $24.73 | 2025 | Xtrac |
| Kerecis Limited | $24.07 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Celgene Corporation | $18.44 | 2024 | Sotyktu |
| Organogenesis INC. | $16.31 | 2025 | Nushield |
| Lnhc, INC | $15.53 | 2025 | Zelsuvmi |
| Vyne Pharmaceuticals INC. | $14.49 | 2021 | |
| Genentech USA, INC. | $14.44 | 2021 | |
| Ucb, INC. | $14.08 | 2021 | |
| Arcutis Biotherapeutics, INC. | $13.97 | 2023 | |
| Mission Pharmacal Company | $12.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Inga Bufano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.